PATRICK J. LORD - 11 Mar 2024 Form 4 Insider Report for LAM RESEARCH CORP (LRCX)

Signature
Marta Woods by Power of Attorney
Issuer symbol
LRCX
Transactions as of
11 Mar 2024
Net transactions value
-$3,202,737
Form type
4
Filing time
13 Mar 2024, 16:41:34 UTC
Previous filing
05 Mar 2024
Next filing
30 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LRCX Common Stock Sale $92,398 -100 -1.3% $923.98 7,866 11 Mar 2024 Direct F1, F2
transaction LRCX Common Stock Sale $462,255 -500 -6.4% $924.51 7,366 11 Mar 2024 Direct F1, F2, F3
transaction LRCX Common Stock Sale $740,720 -800 -11% $925.90 6,566 11 Mar 2024 Direct F1, F2, F4
transaction LRCX Common Stock Sale $463,545 -500 -7.6% $927.09 6,066 11 Mar 2024 Direct F1, F2, F5
transaction LRCX Common Stock Sale $348,068 -375 -6.2% $928.18 5,691 11 Mar 2024 Direct F1, F2, F6
transaction LRCX Common Stock Sale $628,558 -676 -12% $929.82 5,015 11 Mar 2024 Direct F1, F2, F7
transaction LRCX Common Stock Sale $306,250 -329 -6.6% $930.85 4,686 11 Mar 2024 Direct F1, F2, F8
transaction LRCX Common Stock Sale $93,263 -100 -2.1% $932.63 4,586 11 Mar 2024 Direct F1, F2
transaction LRCX Common Stock Sale $67,681 -72 -1.6% $940.01 4,514 11 Mar 2024 Direct F1, F2, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 27, 2023.
F2 The amount reported includes shares subject to unvested restricted stock units.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $924.15 to $925.00, inclusive.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $925.44 to $926.21, inclusive.
F5 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $926.66 to $927.58, inclusive.
F6 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $927.94 to $928.46, inclusive.
F7 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $929.33 to $930.25, inclusive.
F8 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $930.39 to $931.05, inclusive.
F9 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $939.93 to $940.16, inclusive.

Remarks:

This is form two of two forms, to report the 10b5-1 transactions dated March 11, 2024.